Current Medicinal Chemistry

The Molecular Biology of TRAIL-Mediated Signaling and its PotentialTherapeutic Exploitation in Hematopoietic Malignancies
pp. 2091-2100(10)
Authors: Boehrer, Simone; Nowak, Daniel; Hoelzer, Dieter; Mitrou, Paris S.; Uwe Chow, Kai

Development of Heparanase Inhibitors for Anti-Cancer Therapy
pp. 2101-2111(11)
Authors: Miao, Hua-Quan; Liu, Hu; Navarro, Elizabeth; Kussie, Paul; Zhu, Zhenping

Prognostic Value of Leukocytosis in Acute Coronary Syndromes: The Cinderella of the Inflammatory Markers
pp. 2113-2118(6)
Authors: Nunez, J.; Nunez, E.; Sanchis, J.; Bodí, V.; Llacer, A.

The Role of Insertion Allele of Angiotensin Converting Enzyme Gene in Higher Endurance Efficiency and Some Aspects of Pathophysiological and Drug Effects
pp. 2119-2126(8)
Authors: Dekany, M.; Harbula, I.; Berkes, I.; Gyore, I.; Falus, A.; Pucsok, J.

Diabetic Pregnancies: The Challenge of Developing in a Pro-Inflammatory Environment
pp. 2127-2138(12)
Authors: Jawerbaum, A.; Gonzalez, E.

PET Tracers for Imaging of the Dopaminergic System
pp. 2139-2153(15)
Authors: Elsinga, Philip H.; Hatano, Kentaro; Ishiwata, Kiichi

The Features and Shortcomings for Gene Delivery of Current Non-Viral Carriers
pp. 2155-2161(7)
Authors: Kodama, Kota; Katayama, Yoshiki; Shoji, Yoko; Nakashima, Hideki

Chemical Countermeasures for the Control of Bacterial Biofilms: Effective Compounds and Promising Targets
pp. 2163-2177(15)
Authors: Musk Jr., Dinty J.; Hergenrother, Paul J.

Towards a Unifying Hypothesis of Alzheimer's Disease: Cholinergic System Linked to Plaques, Tangles and Neuroinflammation
pp. 2179-2188(10)
Author: Sivaprakasam, Kannan

Cellular Mechanisms and Prospective Applications of Hypericin in Photodynamic Therapy
pp. 2189-2204(16)
Authors: Kiesslich, Tobias; Krammer, Barbara; Plaetzer, Kristjan

Isoniazid is Not a Lead Compound for its Pyridyl Ring Derivatives,Isonicotinoyl Amides, Hydrazides, and Hydrazones: A Critical Review
pp. 2205-2219(15)
Authors: Scior, T.; Garces-Eisele, S. J.